Day One Biopharmaceuticals: Commercial Performance With Catalysts Ahead
Source: SeekingAlpha
2026-02-27 15:29:35 ET
...
Read the full article on Seeking Alpha
For further details see:
Day One Biopharmaceuticals: Commercial Performance With Catalysts Ahead
Day One Biopharmaceuticals Inc.
NASDAQ: DAWN
DAWN Trading
0.57% G/L:
$21.285 Last:
3,246,615 Volume:
$21.19 Open:
DAWN Latest News
March 06, 2026 06:09:06 pm
Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions
March 06, 2026 04:01:00 pm
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Day One Biopharmaceuticals, Inc. (DAWN)
DAWN Stock Data
$1,169,987,345
82,448,428
0.79%
52
N/A
Biotechnology & Life Sciences
Healthcare
US
Brisbane
